ARMOUR Residential REIT stock
ARRNYSEARMOUR Residential REIT, Inc., Real EstateISIN US0423157058
31Score 31 out of 100, Weak
Price and trend
38 / 100
Price history
−29% in one yearThe chart shows daily closes over 19 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 25% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 39).
The price is 36% below its 52-week high. Largest decline in 19 years: 97% (September 2009 to November 2026).
Chart figures for advanced users
- SMA 50$13.81
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$16.26
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)39
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$12.13
- The lowest closing price of the last twelve months.
- Resistance$19.12
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- ARMOUR Residential REIT, Inc. belongs to the REIT (Mortgage) industry (United States) and, with a market value of $1.72B, is number 6 of 19 companies in its industry on MEQIRI.
- MEQIRI Score 31 out of 100 (Weak): rank 322 of 327 in Real Estate, median 55.
- For real estate investment trusts (REITs) what counts is funds from operations (FFO and AFFO). The P/E and the payout ratio of earnings say little here, because depreciation on properties depresses earnings.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- DilutionShare count up 645% since 2020.Capital allocation 24
- Dividend at riskDividend yield 23.7%. At yields this high (15% or more), the dividend was cut by at least a fifth within a year in 69 of 100 cases from 2011 to 2025, against 7 of 100 at 2 to 4%.Capital allocation 24
- Loss-makingLoss of $52.08M over the last 12 months.Fundamentals 37
The score is held back by momentum and profitability.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredNo fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Sep 2026, revenue fell 62.2% on the same quarter a year earlier. Revenue swung sharply, with 2 of 7 years negative. From 2019 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 97%, operating 74%, net 25%. Last 12 months: net −6%. From 2019 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 17 Feb 2027in 97 days
- Last reported
- 21 Oct 2026EPS reported $0.71 (expected $0.71)in line with expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 4.3% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $2.87−1.8%
- Revenue
- $467.33M0.0%
- Earnings per share
- $2.78−4.3%
- Revenue
- $511.38M−5.7%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −0.7%No guidance given: a range bound market with the Fed on hold is expected, and no capital raise is planned for now.
“While favorable market technicals are expected to provide a range-bound environment through the summer, we remain mindful of forces outside our market that could disrupt this stability.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 23 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $10,085 in total. One insider sold, $564,418 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at ARMOUR Residential REIT
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
327 rated companies in Real Estate
- This company
- 31
- Sector median
- 55
Categories against the sector medianMedian of 327 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in REIT (Mortgage)
The next larger and next smaller companies by market value
- AGNC InvestmentAGNC $10.8B41
- Starwood Property TrustSTWD $4.36B34
- Dynex CapitalDX $2.71B42
- Blackstone Mortgage TrustBXMT $1.83B38
- Ellington FinancialEFC $1.45B56
- Ladder CapitalLADR $1.09B48
- Orchid Island CapitalORC $926.36M45
- PennyMac Mortgage Investment TrustPMT $650.53M42
ETFs that hold ARMOUR Residential REIT
Held by 14 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Global X Superdividend UCITS ETF USDUDIV | 0.76% | 0.45% | €842.65M |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.10% | 0.30% | €2.28B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.06% | 0.30% | €2.17B |
Show 5 more
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.06% | 0.30% | €185.82M |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.06% | 0.30% | €4.22B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.03% | 0.30% | €944.34M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 18 Sep 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.